Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades ObsEva to Neutral

HC Wainwright & Co. Downgrades ObsEva to Neutral

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades ObsEva (NASDAQ:OBSV) from Buy to Neutral.

byBenzinga Newsdesk

August 30, 2022

1 minute read

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades ObsEva (NASDAQ:OBSV) from Buy to Neutral.

News

Blend Partners With MeridianLink To Deliver A More Streamlined Digital Lending Experience

By Benzinga Newsdesk

October 10, 8:20 AM

Blend, a leading provider of cloud banking services, today announced an integration with MeridianLink, Inc. (NYSE:MLNK), a leading provider of modern software platforms for financial institutions and consumer reporting

BLND

News

Rivian Reducing Size Of Team By 6%

By Bill Haddad

July 27, 3:45 PM

https://twitter.com/EdLudlow/status/1552379363466784768

RIVN

Terraform Labs Founder And CFO Both Set For Release On $436K Bail

By Murtuza Merchant

May 12, 8:55 AM

Terraform Labs (CRYPTO: LUNA) co-founder Do Kwon and former CFO Han Chong-joon have been granted conditional release by a Montenegrin court after they each posted bail of 400,000 euros (U.S.$436,000).

LUNA

Shuttle Pharmaceuticals Completes Manufacturing Of Active Pharmaceutical Ingredient For Use In Clinical Trial

By Happy Mohamed

August 3, 9:07 AM

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT), today

SHPH

HC Wainwright & Co. Downgrades ObsEva to Neutral

Related Posts

Blend Partners With MeridianLink To Deliver A More Streamlined Digital Lending Experience

Rivian Reducing Size Of Team By 6%

Terraform Labs Founder And CFO Both Set For Release On $436K Bail

Shuttle Pharmaceuticals Completes Manufacturing Of Active Pharmaceutical Ingredient For Use In Clinical Trial